[This corrects the article DOI: 10.3389/jpps.2024.12434.].
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11807734 | PMC |
http://dx.doi.org/10.3389/jpps.2025.14083 | DOI Listing |
Front Pharmacol
February 2025
Department of Hepatobiliary Pancreatic Surgery, The Affiliated Hospital of Qingdao University, Qingdao, China.
[This corrects the article DOI: 10.3389/fphar.2024.
View Article and Find Full Text PDFMol Med Rep
May 2025
The Pancreas Center, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu 210029, P.R. China.
Following the publication of this paper, and subsequently to the publication of a corrigendum (DOI: 10.3892/mmr.2022.
View Article and Find Full Text PDFCurr Cancer Drug Targets
February 2025
Department of Endocrinology and Metabolism, Gongli Hospital, Naval Medical University, Shanghai, 200135, China.
In the article titled "PIWIL1 Promotes Malignant Progression of Papillary Thyroid Carcinoma by Inducing EVA1A Expression" published in Current Cancer Drug Targets, Volume 24, No. 2, 2024, pp. 192-203, the authors have identified errors in Figures 6 (E, F) and 7 (E, F).
View Article and Find Full Text PDFFront Oncol
January 2025
Department of Pharmacy, Xinjiang Key Laboratory of Neurological Diseases, Xinjiang Clinical Research Center for Nervous System Diseases, Second Affiliated Hospital of Xinjiang Medical University, Ürümqi, Xinjiang, China.
[This corrects the article DOI: 10.3389/fonc.2024.
View Article and Find Full Text PDFJ Pharm Pharm Sci
January 2025
Yantai Key Laboratory of Nanomedicine and Advanced Preparations, Yantai Institute of Materia Medica, Yantai, Shandong, China.
[This corrects the article DOI: 10.3389/jpps.2024.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!